Literature DB >> 30999018

Association between the mannose-binding lectin (MBL)-2 gene variants and serum MBL with pulmonary tuberculosis: An update meta-analysis and systematic review.

Xiang Tong1, Qunfang Wan1, Zhenzhen Li2, Sitong Liu1, Jizhen Huang1, Man Wu1, Hong Fan3.   

Abstract

In recent years, many studies have demonstrated that the MBL-2 gene polymorphisms may be associated with pulmonary tuberculosis (PTB) susceptibility. Moreover, some studies have shown that serum MBL levels were influenced by the MBL-2 gene polymorphisms and that it plays an important role in tuberculosis infection. However, the results of these studies were inconsistent and underpowered. The current meta-analysis and systematic review aimed to evaluate the association between the MBL-2 gene polymorphisms and serum MBL levels with PTB. Finally, 30 eligible articles were included in the study. The overall results indicated that the MBL-2 rs1800450 (54 A/B) and rs5030737 (52 A/D) polymorphisms were risk factors for PTB, but the MBL-2 rs1800451 (57 A/C) and rs7095891 (+4 P/Q) polymorphisms as protective factors against PTB. No associations were found in the other three polymorphisms (exon 1, rs7096206 (-221 X/Y), and rs11003125 (-550 H/L) of the MBL-2 gene. In addition, we could not detect any significant differences between haplotypes among PTB patients and healthy controls. More important, the meta-analysis results indicated that the serum MBL levels in patients with PTB were significantly lower than those in healthy controls (SMD = 0.43, 95% CI = 0.33-0.52). This study suggested that the MBL-2 gene polymorphisms may be involved in the pathogenesis of PTB, and serum MBL may be a biomarker for the diagnosis of PTB. More rigorous research is needed in the future to confirm these findings further.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Background; MBL; Meta-analysis; Polymorphism; Susceptibility; Tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 30999018     DOI: 10.1016/j.micpath.2019.04.023

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Mannose-binding lectin 2 gene polymorphisms and their association with tuberculosis in a Chinese population.

Authors:  Jun-Xian Zhang; Wen-Ping Gong; Dong-Lin Zhu; Hui-Ru An; You-Rong Yang; Yan Liang; Jie Wang; Jing Tang; Wei-Guo Zhao; Xue-Qiong Wu
Journal:  Infect Dis Poverty       Date:  2020-04-29       Impact factor: 4.520

Review 2.  The ambiguous role of mannose-binding lectin (MBL) in human immunity.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Open Med (Wars)       Date:  2021-02-17

3.  Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseases.

Authors:  Esther Willems; Laura Lorés-Motta; Andrea Zanichelli; Chiara Suffritti; Michiel van der Flier; Renate G van der Molen; Jeroen D Langereis; Joris van Drongelen; Lambert P van den Heuvel; Elena Volokhina; Nicole Caj van de Kar; Jenneke Keizer-Garritsen; Michael Levin; Jethro A Herberg; Federico Martinon-Torres; Hans Jtc Wessels; Anita de Breuk; Sascha Fauser; Carel B Hoyng; Anneke I den Hollander; Ronald de Groot; Alain J van Gool; Jolein Gloerich; Marien I de Jonge
Journal:  Clin Transl Immunology       Date:  2020-12-09

4.  Association of ficolin-1 and ficolin-3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population.

Authors:  Ye Li; En-Qing You; Wen-Hong Lin; Xiao-Ning Liu; De-Pei Shen; Xin-Li Zhang; Dong-Chun Ma; Hong-Miao Li
Journal:  J Clin Lab Anal       Date:  2021-02-16       Impact factor: 2.352

5.  Association between polymorphisms in mannose-binding lectin 2 gene with pulmonary tuberculosis susceptibility.

Authors:  Wenhao Shen; Li Xiao; Yang Li; Daming Zhou; Wei Zhang
Journal:  Hereditas       Date:  2020-08-03       Impact factor: 3.271

Review 6.  The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System.

Authors:  Anna S Świerzko; Maciej Cedzyński
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.